Physiology of the Pituitary Hormone Secretion

[1]  P. Kaeser,et al.  Mechanisms and regulation of dopamine release , 2019, Current Opinion in Neurobiology.

[2]  M. Pashenkov,et al.  Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions , 2019, Journal of Neuroimmune Pharmacology.

[3]  O. Savvidou,et al.  Glucocorticoid signaling and osteoarthritis , 2019, Molecular and Cellular Endocrinology.

[4]  E. Bono,et al.  Melanocortin-1 Receptor Positively Regulates Human Artery Endothelial Cell Migration. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[5]  M. Korbonits,et al.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature , 2018, Pharmacological Reviews.

[6]  Polymnia Georgiou,et al.  Oxytocin and opioid addiction revisited: old drug, new applications , 2018, British journal of pharmacology.

[7]  S. Kyo,et al.  Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system , 2018, Reproductive medicine and biology.

[8]  R. Kineman,et al.  Multiple signaling pathways convey central and peripheral signals to regulate pituitary function: Lessons from human and non-human primate models , 2018, Molecular and Cellular Endocrinology.

[9]  N. Japundzic-Zigon,et al.  Vasopressin, Central Autonomic Control and Blood Pressure Regulation , 2018, Current Hypertension Reports.

[10]  M. Aguiar-Oliveira,et al.  Hypothalamic abnormalities: Growth failure due to defects of the GHRH receptor. , 2017, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[11]  U. Kaiser,et al.  Gonadotropin regulation by pulsatile GnRH: Signaling and gene expression , 2017, Molecular and Cellular Endocrinology.

[12]  N. Morgenthaler,et al.  Vasopressin: physiology, assessment and osmosensation , 2017, Journal of internal medicine.

[13]  R. Anderson,et al.  Effect of gonadotropin‐inhibitory hormone on luteinizing hormone secretion in humans , 2017, Clinical endocrinology.

[14]  R. Luque,et al.  Cortistatin: A new link between the growth hormone/prolactin axis, stress, and metabolism. , 2017, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[15]  M. Malagón,et al.  Adipokines (Leptin, Adiponectin, Resistin) Differentially Regulate All Hormonal Cell Types in Primary Anterior Pituitary Cell Cultures from Two Primate Species , 2017, Scientific Reports.

[16]  A. Martínez-Fuentes,et al.  Role of the Kiss1/Kiss1r system in the regulation of pituitary cell function , 2016, Molecular and Cellular Endocrinology.

[17]  S. Kyo,et al.  Interactions between Two Different G Protein-Coupled Receptors in Reproductive Hormone-Producing Cells: The Role of PACAP and Its Receptor PAC1R , 2016, International journal of molecular sciences.

[18]  C. Brown.  Magnocellular Neurons and Posterior Pituitary Function. , 2016, Comprehensive Physiology.

[19]  J. Veldhuis,et al.  Pulsatile Cortisol Feedback on ACTH Secretion Is Mediated by the Glucocorticoid Receptor and Modulated by Gender. , 2016, The Journal of clinical endocrinology and metabolism.

[20]  P. Micevych,et al.  Peripheral and Central Mechanisms Involved in the Hormonal Control of Male and Female Reproduction , 2016, Journal of neuroendocrinology.

[21]  L. de Lecea,et al.  Cortistatin Is a Key Factor Regulating the Sex-Dependent Response of the GH and Stress Axes to Fasting in Mice. , 2016, Endocrinology.

[22]  M. AlMalki,et al.  Primary Hypothyroidism with Markedly High Prolactin , 2016, Front. Endocrinol..

[23]  Aaron Naatz,et al.  Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[24]  S. Bloom,et al.  Subcutaneous infusion of kisspeptin‐54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels , 2015, Clinical endocrinology.

[25]  A. Ulloa-Aguirre,et al.  Clinical Applications of Gonadotropins in the Male. , 2016, Progress in molecular biology and translational science.

[26]  E. Ghigo,et al.  Ghrelin Actions on Somatotropic and Gonadotropic Function in Humans. , 2016, Progress in molecular biology and translational science.

[27]  S. Kyo,et al.  Role of thyrotropin-releasing hormone in prolactin-producing cell models , 2015, Neuropeptides.

[28]  S. Bloom,et al.  Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men , 2015, Human reproduction.

[29]  G. Musumeci,et al.  A journey through the pituitary gland: Development, structure and function, with emphasis on embryo-foetal and later development. , 2015, Acta histochemica.

[30]  M. Andermann,et al.  Ghrelin , 2015, Molecular metabolism.

[31]  M. Culler,et al.  In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features , 2015, Scientific Reports.

[32]  R. Kineman,et al.  Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates. , 2015, Endocrinology.

[33]  S. Stojilkovic,et al.  Loss of basal and TRH-stimulated Tshb expression in dispersed pituitary cells. , 2015, Endocrinology.

[34]  M. Locatelli,et al.  Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) , 2014, Molecular and Cellular Endocrinology.

[35]  E. Ghigo,et al.  Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in female primates and male/female mice. , 2014, Endocrinology.

[36]  J. Bains,et al.  Physiological Regulation of Magnocellular Neurosecretory Cell Activity: Integration of Intrinsic, Local and Afferent Mechanisms , 2013, Journal of neuroendocrinology.

[37]  G. Stalla,et al.  Somatostatin receptors: From signaling to clinical practice , 2013, Frontiers in Neuroendocrinology.

[38]  M. Korbonits,et al.  Genetics of pituitary adenomas. , 2013, Frontiers of hormone research.

[39]  R. Salvatori,et al.  Molecular and clinical aspects of GHRH receptor mutations. , 2013, Endocrine development.

[40]  B. W. Jones,et al.  Desensitization, Trafficking, and Resensitization of the Pituitary Thyrotropin-Releasing Hormone Receptor , 2012, Front. Neurosci..

[41]  S. Melmed,et al.  Somatostatin analogs and chimeric somatostatin–dopamine molecules differentially regulate human growth hormone and prolactin gene expression and secretion in vitro , 2012, Molecular and Cellular Endocrinology.

[42]  N. Justice,et al.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin , 2012, Molecular and Cellular Endocrinology.

[43]  D. Grammatopoulos.  Insights into mechanisms of corticotropin‐releasing hormone receptor signal transduction , 2012, British journal of pharmacology.

[44]  K. Tsutsui,et al.  Gonadotropin-inhibitory hormone inhibits GnRH-induced gonadotropin subunit gene transcriptions by inhibiting AC/cAMP/PKA-dependent ERK pathway in LβT2 cells. , 2012, Endocrinology.

[45]  A. Steiger,et al.  Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. , 2012, The Journal of clinical endocrinology and metabolism.

[46]  C. Kahn,et al.  Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. , 2011, Endocrinology.

[47]  S. Bloom,et al.  The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. , 2011, The Journal of clinical endocrinology and metabolism.

[48]  L. de Lecea,et al.  Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin. , 2011, Endocrinology.

[49]  R. Kineman,et al.  A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance , 2011, PloS one.

[50]  H. Kanasaki,et al.  Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells , 2011, Molecular and Cellular Endocrinology.

[51]  R. Kineman,et al.  Kisspeptin regulates gonadotroph and somatotroph function in nonhuman primate pituitary via common and distinct signaling mechanisms. , 2011, Endocrinology.

[52]  Richard Bertram,et al.  Ion channels and signaling in the pituitary gland. , 2010, Endocrine reviews.

[53]  B. Jenks,et al.  BDNF stimulates Ca2+ oscillation frequency in melanotrope cells of Xenopus laevis: contribution of IP3-receptor-mediated release of intracellular Ca2+ to gene expression. , 2010, General and comparative endocrinology.

[54]  M. Dattani,et al.  Genetic causes and treatment of isolated growth hormone deficiency—an update , 2010, Nature Reviews Endocrinology.

[55]  S. Grottoli,et al.  Ghrelin and anterior pituitary function. , 2010, Frontiers of hormone research.

[56]  G. Anifandis,et al.  Effect of Ghrelin and Thyrotropin-releasing Hormone on Prolactin Secretion in Normal Women , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[57]  D. Leroith,et al.  Biological effects of growth hormone on carbohydrate and lipid metabolism. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[58]  T. Plant,et al.  Studies of the Localisation of Kisspeptin Within the Pituitary of the Rhesus Monkey (Macaca mulatta) and the Effect of Kisspeptin on the Release of Non‐Gonadotropic Pituitary Hormones , 2009, Journal of neuroendocrinology.

[59]  K. Catt,et al.  The hypothalamic GnRH pulse generator: multiple regulatory mechanisms , 2009, Trends in Endocrinology & Metabolism.

[60]  C. Messini,et al.  Growth hormone and prolactin response to ghrelin during the normal menstrual cycle , 2009, Clinical endocrinology.

[61]  W. Saeger,et al.  Expression of Ghrelin and its Receptor in Human Tissues , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[62]  K. Matsumoto,et al.  Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovines. , 2009, Domestic animal endocrinology.

[63]  M. Malagón,et al.  Understanding the Multifactorial Control of Growth Hormone Release by Somatotropes , 2009, Annals of the New York Academy of Sciences.

[64]  S. Asa,et al.  The pathogenesis of pituitary tumors. , 2009, Annual review of pathology.

[65]  E. Ghigo,et al.  Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. , 2008, The Journal of clinical endocrinology and metabolism.

[66]  Adam J Pawson,et al.  Potent action of RFamide-related peptide-3 on pituitary gonadotropes indicative of a hypophysiotropic role in the negative regulation of gonadotropin secretion. , 2008, Endocrinology.

[67]  M. Malagón,et al.  Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead , 2008, Molecular and Cellular Endocrinology.

[68]  L. Hofland.  Somatostatin and somatostatin receptors in Cushing's disease , 2008, Molecular and Cellular Endocrinology.

[69]  P. Maruna,et al.  Ghrelin as an Acute-phase Reactant during Postoperative Stress Response , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[70]  E. Ghigo,et al.  Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans , 2008, Neuropeptides.

[71]  N. Sherwood,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice , 2008, Molecular and Cellular Endocrinology.

[72]  R. Kineman,et al.  Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH. , 2007, Endocrinology.

[73]  N. Goldenberg,et al.  Factors regulating growth hormone secretion in humans. , 2007, Endocrinology and metabolism clinics of North America.

[74]  H. Vaudry,et al.  Discovery of growth hormone-releasing hormones and receptors in nonmammalian vertebrates , 2007, Proceedings of the National Academy of Sciences.

[75]  R. Kineman,et al.  Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. , 2006, Journal of molecular endocrinology.

[76]  R. Kineman,et al.  Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. , 2006, American journal of physiology. Endocrinology and metabolism.

[77]  R. Cone,et al.  The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[78]  E. Ghigo,et al.  Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes. , 2006, Journal of molecular endocrinology.

[79]  I. Shimon,et al.  Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas. , 2006, The Journal of clinical endocrinology and metabolism.

[80]  S. Grottoli,et al.  Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[81]  S. Wardlaw,et al.  Stimulation of the Hypothalamic-Pituitary-Adrenal Axis with the Opioid Antagonist Nalmefene , 2005, Pituitary.

[82]  H. Okinaga,et al.  Mechanisms of TRH-induced GH release (paradoxical response) in human somatotroph adenoma cells. , 2005, Endocrine journal.

[83]  D. Hoyer,et al.  Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. , 2005, American journal of physiology. Endocrinology and metabolism.

[84]  A. Steiger,et al.  Ghrelin Stimulates Appetite, Imagination of Food, GH, ACTH, and Cortisol, but does not Affect Leptin in Normal Controls , 2005, Neuropsychopharmacology.

[85]  B. Jenks,et al.  Neuronal, Neurohormonal, and Autocrine Control of Xenopus Melanotrope Cell Activity , 2005, Annals of the New York Academy of Sciences.

[86]  M. Papotti,et al.  Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor , 2005, Clinical endocrinology.

[87]  J. Rivier,et al.  Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. , 2004, The Journal of clinical endocrinology and metabolism.

[88]  E. Hahn,et al.  Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage , 2004, Regulatory Peptides.

[89]  U. Kaiser,et al.  Regulation of gonadotropins by inhibin and activin. , 2004, Seminars in reproductive medicine.

[90]  J. Kros,et al.  Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues , 2004, Clinical endocrinology.

[91]  S. Lamberts,et al.  The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. , 2004, The Journal of clinical endocrinology and metabolism.

[92]  K. Catt,et al.  Corticotropin releasing hormone receptors: two decades later , 2004, Peptides.

[93]  M. Wilson,et al.  Leptin administration increases nocturnal concentrations of luteinizing hormone and growth hormone in juvenile female rhesus monkeys. , 2003, The Journal of clinical endocrinology and metabolism.

[94]  B. Jenks,et al.  Expression and characterization of the extracellular Ca(2+)-sensing receptor in melanotrope cells of Xenopus laevis. , 2003, Endocrinology.

[95]  G. Lincoln,et al.  Clock Genes and the Long‐Term Regulation of Prolactin Secretion: Evidence for a Photoperiod/Circannual Timer in the Pars Tuberalis , 2003, Journal of neuroendocrinology.

[96]  F. Pralong,et al.  Neuropeptide Y: the universal soldier , 2003, Cellular and Molecular Life Sciences CMLS.

[97]  M. Papotti,et al.  Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. , 2002, The Journal of clinical endocrinology and metabolism.

[98]  M. Papotti,et al.  Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. , 2002, The Journal of clinical endocrinology and metabolism.

[99]  M. Belyea,et al.  Preterm infants born at less than 31 weeks' gestation have improved growth in cycled light compared with continuous near darkness. , 2002, The Journal of pediatrics.

[100]  Importance of inhibin B in the regulation of FSH secretion in the human male. , 2001, The Journal of clinical endocrinology and metabolism.

[101]  K. Moriyama,et al.  A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[102]  Z. Blumenfeld,et al.  Inhibin, Activin, and Follistatin in Human Fetal Pituitary and Gonadal Physiology , 2001, Annals of the New York Academy of Sciences.

[103]  H. Vaudry,et al.  Amphibian Melanotrope Subpopulations Respond Differentially to Hypothalamic Secreto-Inhibitors , 2001, Neuroendocrinology.

[104]  O. Nishimura,et al.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.

[105]  A. Tomoda,et al.  Effects of exogenous melatonin on pituitary hormones in humans. , 2001, Clinical physiology.

[106]  Y. Kato,et al.  Roles and mechanisms of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in growth hormone and prolactin secretion. , 2001, Endocrine journal.

[107]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[108]  M. Kikuchi,et al.  A novel avian hypothalamic peptide inhibiting gonadotropin release. , 2000, Biochemical and biophysical research communications.

[109]  J. van Buyten,et al.  Endocrine consequences of long-term intrathecal administration of opioids. , 2000, The Journal of clinical endocrinology and metabolism.

[110]  G. Nagy,et al.  Prolactin: structure, function, and regulation of secretion. , 2000, Physiological reviews.

[111]  F. Kiefer,et al.  Comparison of the effects of endothelin-1 and -3 on secretion of pituitary hormones in healthy male volunteers. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[112]  P. Lavie,et al.  Long-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal men. , 2000, Human reproduction.

[113]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[114]  M. Forsling,et al.  The effect of melatonin administration on pituitary hormone secretion in man , 1999, Clinical endocrinology.

[115]  S H Shin,et al.  Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells. , 1999, European journal of endocrinology.

[116]  Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH) , 1999, Clinical endocrinology.

[117]  F. Vandesande,et al.  Effects of Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) on cAMP Formation and Growth Hormone Release from Chicken Anterior Pituitary Cells a , 1998, Annals of the New York Academy of Sciences.

[118]  W. Crowley,et al.  Activin: an endocrine or paracrine agent? , 1998, European journal of endocrinology.

[119]  H. Fehm,et al.  Regulation of gonadotrophin secretion by inhibin, testosterone and gonadotrophin-releasing hormone in pituitary cell cultures of male monkeys. , 1998, The Journal of endocrinology.

[120]  M. Wheeler,et al.  Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women , 1998, Clinical endocrinology.

[121]  G. Leng,et al.  Sex, parturition and motherhood without oxytocin? , 1998, The Journal of endocrinology.

[122]  E. Arvat,et al.  Effects of Dexamethasone and Alprazolam, a Benzodiazepine, on the Stimulatory Effect of Hexarelin, a Synthetic GHRP, on ACTH, Cortisol and GH Secretion in Humans , 1998, Neuroendocrinology.

[123]  G. Delitala,et al.  Opioid-Receptor Blockade Blunts Growth Hormone (GH) Secretion Induced by GH-Releasing Hormone in the Human Male , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[124]  O. Prospero-Garcia,et al.  A cortical neuropeptide with neuronal depressant and sleep-modulating properties , 1996, Nature.

[125]  F. Cesselin.  Opioid and anti‐opioid peptides , 1995, Fundamental & clinical pharmacology.

[126]  J. Holly,et al.  The effect of recombinant IGF‐I on anterior pituitary function in healthy volunteers , 1994, Clinical endocrinology.

[127]  R. Kineman,et al.  Paradoxical effects of dopamine (DA): Gi alpha 3 mediates DA inhibition of PRL release while masking its PRL-releasing activity. , 1994, Endocrinology.

[128]  H. Watanobe,et al.  Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men. , 1994, Biochemical and biophysical research communications.

[129]  J. Kuhn,et al.  Effects of a slow‐release formulation of the new somatostatin analogue lanreotide in TSH‐secreting pituitary adenomas , 1994, Clinical endocrinology.

[130]  E. Nieschlag,et al.  Exogenous gonadotrophin-releasing hormone (GnRH) stimulates LH secretion in male monkeys (Macaca fascicularis) treated chronically with high doses of a GnRH antagonist. , 1992, The Journal of endocrinology.

[131]  K. Mori,et al.  Structure and expression of a human oxytocin receptor , 1992, Nature.

[132]  S. Bloom,et al.  Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3. , 1992, The Journal of endocrinology.

[133]  G. Chrousos,et al.  Spontaneous and glucocorticoid-inhibited adrenocorticotropic hormone and cortisol secretion are similar in healthy young and old men. , 1991, The Journal of clinical endocrinology and metabolism.

[134]  T. Jolín,et al.  The role of somatostatin and/or dopamine in basal and TRH-stimulated TSH release in food-restricted rats. , 1991, Acta endocrinologica.

[135]  S. Yen,et al.  Amplification of pulsatile LH secretion by exogenous melatonin in women. , 1991, The Journal of clinical endocrinology and metabolism.

[136]  K. Pau,et al.  Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques. , 1990, Endocrinology.

[137]  S. Lamberts,et al.  Regulation of prolactin secretion at the level of the lactotroph. , 1990, Physiological reviews.

[138]  B. Burguera,et al.  Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. , 1990, Neuroendocrinology.

[139]  A. Grossman,et al.  THE PITUITARY‐ADRENAL RESPONSE TO CRF‐41 IS UNALTERED BY INTRAVENOUS SOMATOSTATIN IN NORMAL SUBJECTS , 1989, Clinical endocrinology.

[140]  Joseph B. Martin,et al.  Potential involvement of galanin in the regulation of fluid homeostasis in the rat , 1989, Regulatory Peptides.

[141]  E. Mohr,et al.  Expression of the vasopressin and oxytocin genes in rats occurs in mutually exclusive sets of hypothalamic neurons , 1988, FEBS letters.

[142]  S. Lamberts.  The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. , 1988, Endocrine reviews.

[143]  J. Livesey,et al.  The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse. , 1988, Endocrinology.

[144]  R. Brenner,et al.  The effect of simultaneous versus sequential estradiol and progesterone treatments on prolactin production in monkey pituitary cell cultures. , 1988, Endocrinology.

[145]  S. Ying.  Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. , 1988, Endocrine reviews.

[146]  C. Wood,et al.  Does cortisol inhibit vasopressin secretion in sheep? , 1988, Domestic animal endocrinology.

[147]  W. Oelkers,et al.  Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man. , 1988, The Journal of clinical endocrinology and metabolism.

[148]  N. Mauras,et al.  Appraising the instantaneous secretory rates of luteinizing hormone and testosterone in response to selective mu opiate receptor blockade in late pubertal boys. , 1987, Journal of andrology.

[149]  M. Venetikou,et al.  Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours. , 1987, Acta Endocrinologica.

[150]  B. Allolio,et al.  Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. , 1987, Acta endocrinologica.

[151]  R. Valcavi,et al.  EFFECT OF ORAL ADMINISTRATION OF MELATONIN ON GH RESPONSES TO GRF 1–44 IN NORMAL SUBJECTS , 1987, Clinical endocrinology.

[152]  G. Dayanithi,et al.  Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis , 1987, Nature.

[153]  A. Pfeiffer,et al.  Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[154]  R. Nishioka,et al.  In vitro effects of somatostatin and urotensin II on prolactin and growth hormone secretion in tilapia, Oreochromis mossambicus. , 1986, General and comparative endocrinology.

[155]  B. Posner,et al.  Effect of insulin-like growth factors on human foetal, adult normal and tumour pituitary function in tissue culture. , 1986, Acta endocrinologica.

[156]  J. Arendt,et al.  THE EFFECTS OF EXOGENOUS MELATONIN ON ENDOCRINE FUNCTION IN MAN , 1986, Clinical endocrinology.

[157]  D. Esposti,et al.  Effect of an acute injection of melatonin on the basal secretion of hypophyseal hormones in prepubertal and pubertal healthy subjects. , 1986, Acta endocrinologica.

[158]  A. Caiazza,et al.  Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. , 1986, Gynecologic and obstetric investigation.

[159]  J. Kraicer,et al.  Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin. , 1985, Neuroendocrinology.

[160]  J. Connell,et al.  THE ROLE OF PLASMA OSMOLALITY, ANGIOTENSIN II AND DOPAMINE IN VASOPRESSIN RELEASE IN MAN , 1985, Clinical endocrinology.

[161]  P. Seeburg,et al.  A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormone , 1985, Nature.

[162]  B. Rolls,et al.  Angiotensin II-induced thirst and vasopressin release in man. , 1985, Clinical science.

[163]  T. Yamaji,et al.  Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture. , 1985, The Journal of clinical endocrinology and metabolism.

[164]  J. Blaustein,et al.  1-(o-Chlorophenyl)-1 (p-chlorophenyl)2,2,2-trichloroethane induces functional progestin receptors in the rat hypothalamus and pituitary gland. , 1984, Endocrinology.

[165]  L. Gooren,et al.  Somatostatin inhibits prolactin release from the lactotroph primed with oestrogen and cyproterone acetate in man. , 1984, The Journal of endocrinology.

[166]  J. Fahrenkrug,et al.  Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyis. , 1984, Endocrinology.

[167]  F. Antoni.  Novel ligand specificity of pituitary vasopressin receptors in the rat. , 1984, Neuroendocrinology.

[168]  A. Matsumoto,et al.  Modulation of Pulsatile Gonadotropin Secretion by Testosterone in Man , 1984 .

[169]  K. Copeland,et al.  Estrogen stimulates growth hormone and somatomedin-C in castrate and intact female baboons. , 1984, The Journal of clinical endocrinology and metabolism.

[170]  A. Grossman,et al.  THE PARTICIPATION OF HYPOTHALAMIC DOPAMINE IN MORPHINE‐INDUCED PROLACTIN RELEASE IN MAN , 1983, Clinical endocrinology.

[171]  B. Bercu,et al.  Pharmacologic effects of melatonin on hypothalamic-adenohypophyseal function in the nonhuman primate. , 1982, Neuroendocrinology.

[172]  R. Martín,et al.  Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis , 1981, Nature.

[173]  Carl Denef,et al.  Dopaminergic stimulation of prolactin release , 1980, Nature.

[174]  E. Zimmerman,et al.  Immunocytochemical localization of angiotensin II and vasopressin in rat hypothalamus: evidence for production in the same neuron. , 1980, Clinical science.

[175]  J. Sowers,et al.  Effect of dexamethsone on luteinizing hormone and follicle stimulating hormone responses to LHRH and to clomiphene in the follicular phase of women with normal menstrual cycles. , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[176]  D. Weightman,et al.  DOPAMINE IS A PHYSIOLOGICAL REGULATOR OF THYROTROPHIN (TSH) SECRETION IN NORMAL MAN , 1979, Clinical endocrinology.

[177]  P. Woolf,et al.  Dopamine affects basal and augmented pituitary hormone secretion. , 1978, The Journal of clinical endocrinology and metabolism.

[178]  J. Nordlund,et al.  The effects of oral melatonin on skin color and on the release of pituitary hormones. , 1977, The Journal of clinical endocrinology and metabolism.

[179]  J. Nedvídková,et al.  Effect of Bromocryptine on the Secretion of Thyrotropic Hormone (TSH), Prolactin (Pr), Human Growth Hormone (HGH), Thyroxine (T4) and Triiodothyroxine (T3) in Hypothyroidism , 1977, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[180]  G. Burrow,et al.  TRH and dopamine interactions affecting pituitary hormones secretion. , 1977, The Journal of clinical endocrinology and metabolism.

[181]  J. Drouin,et al.  Characteristics of the interaction between thyrotropin-releasing hormone and somatostatin for thyrotropin and prolactin release. , 1976, Endocrinology.

[182]  G. Burrow,et al.  Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. , 1975, The Journal of clinical endocrinology and metabolism.

[183]  A. P. Hansen,et al.  Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men. , 1975, The Journal of clinical endocrinology and metabolism.

[184]  R. Guillemin,et al.  Effects of somatostatin on the secretion of thyrotropin and prolactin. , 1974, Endocrinology.

[185]  G. Smythe,et al.  Growth Hormone Responses to Melatonin in Man , 1974, Science.

[186]  B. Rapoport,et al.  Interrelationships in the regulation of TSH and prolactin secretion in man: effects of L-dopa, TRH and thyroid hormone in various combinations. , 1974, The Journal of clinical endocrinology and metabolism.

[187]  G. Burrow,et al.  L-DOPA suppression of thyrotropin-releasing hormone response in man. , 1972, The Journal of clinical endocrinology and metabolism.

[188]  L. Share,et al.  Vasopressin-renin-cortisol interrelations. , 1971, Endocrinology.

[189]  H. Dale.  On some physiological actions of ergot , 1906, The Journal of physiology.